PHARMA - Relationships

Relationships Table

Entities - Color - Target Drug Disease Lo Med Hi
Word 1
Word 1 Count
CAT1
CAT2
Word 2
Word 2 Count
Co-occurrence
Occurence-Centile
Correlation
Overlap-Metric
G-Metric
Eotaxin 2,457 Target Target Xanthine Oxidase 8,860 2 0.00 -1.00 0.00 0.56
Eotaxin 2,457 Target Disease Renal Failure 73,993 2 0.00 -1.00 0.00 0.50
Eotaxin 2,457 Target Disease Pneumonia 81,521 20 0.00 -1.00 0.01 0.56
Eotaxin 2,457 Target Target CCL2 3,560 68 0.02 -0.98 0.03 0.73
Eotaxin 2,457 Target Target Urokinase-Type Plasminogen Activator 3,939 2 0.00 -1.00 0.00 0.58
Eotaxin 2,457 Target Disease Conjunctival Disease 66 1 0.00 -0.99 0.02 0.65
Eotaxin 2,457 Target Disease Celiac Disease 8,026 1 0.00 -1.00 0.00 0.54
Eotaxin 2,457 Target Disease Relapsing Remitting Multiple Sclerosis 2,115 2 0.00 -1.00 0.00 0.60
Eotaxin 2,457 Target Target CXCL10/IP-10 114 5 0.01 -0.98 0.04 0.69
Eotaxin 2,457 Target Disease Diverticulitis 4,735 1 0.00 -1.00 0.00 0.56
Eotaxin 2,457 Target Disease Sarcoidosis 19,176 4 0.00 -1.00 0.00 0.56
Eotaxin 2,457 Target Target CD154 1,512 4 0.00 -1.00 0.00 0.63
Eotaxin 2,457 Target Target Eotaxin-2/CCL24 19 19 0.09 -0.22 1.00 0.76
Eotaxin 2,457 Target Target Histamine H4 Receptor 168 3 0.00 -0.99 0.02 0.66
Eotaxin 2,457 Target Target Alpha-Amylase 7,171 1 0.00 -1.00 0.00 0.54
Eotaxin 2,457 Target Disease Cholesterol 182,390 3 0.00 -1.00 0.00 0.49
Eotaxin 2,457 Target Disease Chronic Lymphocytic Leukemia 11,642 1 0.00 -1.00 0.00 0.53
Eotaxin 2,457 Target Disease Epilepsy 71,172 2 0.00 -1.00 0.00 0.50
Eotaxin 2,457 Target Disease Heartburn 3,957 2 0.00 -1.00 0.00 0.58
Eotaxin 2,457 Target Disease Hypocalcemia 6,174 1 0.00 -1.00 0.00 0.55
Eotaxin 2,457 Target Target APOE 12,771 2 0.00 -1.00 0.00 0.55
Eotaxin 2,457 Target Target Eotaxin-3/CCL26 26 26 0.10 -0.19 1.00 0.77
Eotaxin 2,457 Target Target ERK2 3,287 2 0.00 -1.00 0.00 0.59
Eotaxin 2,457 Target Target Vascular Cell Adhesion Protein 1 31 1 0.00 -0.98 0.03 0.66
Eotaxin 2,457 Target Disease Acute Coronary Syndromes 9,133 2 0.00 -1.00 0.00 0.56
Eotaxin 2,457 Target Disease Allergic Rhinitis 12,280 85 0.02 -0.98 0.03 0.68
Eotaxin 2,457 Target Disease Muscle Weakness 9,178 1 0.00 -1.00 0.00 0.54
Eotaxin 2,457 Target Disease Hyperlipidemia 15,317 1 0.00 -1.00 0.00 0.52
Eotaxin 2,457 Target Disease Scabies 2,670 1 0.00 -1.00 0.00 0.57
AKT3 293 Target Target ERBB3 1,154 3 0.01 -0.99 0.01 0.68
AKT3 293 Target Disease Brain Tumors 16,749 1 0.00 -1.00 0.00 0.57
AKT3 293 Target Target bFGF 9,327 1 0.00 -1.00 0.00 0.58
AKT3 293 Target Disease Breast Cancer 173,695 28 0.00 -0.95 0.10 0.59
AKT3 293 Target Disease Leukemia 162,805 6 0.00 -0.99 0.02 0.56
AKT3 293 Target Disease Pain 409,851 1 0.00 -1.00 0.00 0.50
AKT3 293 Target Disease Autism 20,962 1 0.00 -1.00 0.00 0.56
AKT3 293 Target Disease Amyotrophic Lateral Sclerosis 14,006 3 0.00 -0.99 0.01 0.60
AKT3 293 Target Target EGF 27,487 8 0.00 -0.99 0.03 0.61
AKT3 293 Target Target Cox-2 21,583 1 0.00 -1.00 0.00 0.56
AKT3 293 Target Disease Hepatitis 163,842 1 0.00 -1.00 0.00 0.51
AKT3 293 Target Target Collagen 138,882 6 0.00 -0.99 0.02 0.56
AKT3 293 Target Disease Cholesterol 182,390 1 0.00 -1.00 0.00 0.51
AKT3 293 Target Disease Rheumatoid Arthritis 78,952 1 0.00 -1.00 0.00 0.53
AKT3 293 Target Disease Salivary Gland Cancer 202 1 0.00 -1.00 0.00 0.70
AKT3 293 Target Disease Sarcoidosis 19,176 1 0.00 -1.00 0.00 0.56
AKT3 293 Target Disease Epilepsy 71,172 4 0.00 -0.99 0.01 0.57
AKT3 293 Target Target BRAF 4,766 8 0.01 -0.99 0.03 0.67
AKT3 293 Target Disease Lung Cancer 91,416 9 0.00 -0.98 0.03 0.58
AKT3 293 Target Disease Seizures 66,465 5 0.00 -0.99 0.02 0.57
AKT3 293 Target Target Glutathione S-Transferase Mu 2 8 1 0.02 -0.93 0.12 0.74